{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:05:50Z","timestamp":1791392750687,"version":"4.3.3"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T00:00:00Z","timestamp":1473033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/nm.4173","type":"journal-article","created":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T11:37:52Z","timestamp":1473075472000},"page":"1151-1159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":190,"title":["Purinergic receptors in the carotid body as a new drug target for controlling hypertension"],"prefix":"10.1038","volume":"22","author":[{"given":"Wioletta","family":"Pijacka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davi J A","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E K","family":"Ratcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9435-726X","authenticated-orcid":false,"given":"Angus K","family":"Nightingale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma C","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina P","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedito H","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona D","family":"McBryde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-2591","authenticated-orcid":false,"given":"Ana P","family":"Abdala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian F R","family":"Paton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,5]]},"reference":[{"key":"BFnm4173_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","volume":"129","author":"AS Go","year":"2014","unstructured":"Go, A.S. et al. Executive summary: heart disease and stroke statistics\u20142014 update: a report from the American Heart Association. Circulation 129, 399\u2013410 (2014).","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"BFnm4173_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/00019053-200321001-00004","volume":"21","author":"A Lloyd","year":"2003","unstructured":"Lloyd, A., Schmieder, C. & Marchant, N. Financial and health costs of uncontrolled blood pressure in the United Kingdom. Pharmacoeconomics 21 (Suppl. 1), 33\u201341 (2003).","journal-title":"Pharmacoeconomics"},{"key":"BFnm4173_CR3","doi-asserted-by":"crossref","unstructured":"Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903\u20131913 (2002).","DOI":"10.1016\/S0140-6736(02)11911-8"},{"key":"BFnm4173_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","volume":"365","author":"PM Kearney","year":"2005","unstructured":"Kearney, P.M. et al. Global burden of hypertension: analysis of worldwide data. Lancet 365, 217\u2013223 (2005).","journal-title":"Lancet"},{"key":"BFnm4173_CR5","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1161\/HYPERTENSIONAHA.111.00601","volume":"61","author":"RM Carey","year":"2013","unstructured":"Carey, R.M. Resistant hypertension. Hypertension 61, 746\u2013750 (2013).","journal-title":"Hypertension"},{"key":"BFnm4173_CR6","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nrd3315","volume":"9","author":"A Plump","year":"2010","unstructured":"Plump, A. Accelerating the pulse of cardiovascular R&D. Nat. Rev. Drug Discov. 9, 823\u2013824 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnm4173_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.108.787630","volume":"118","author":"MJ Brown","year":"2008","unstructured":"Brown, M.J. Aliskiren. Circulation 118, 773\u2013784 (2008).","journal-title":"Circulation"},{"key":"BFnm4173_CR8","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","volume":"373","author":"H Krum","year":"2009","unstructured":"Krum, H. et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373, 1275\u20131281 (2009).","journal-title":"Lancet"},{"key":"BFnm4173_CR9","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1161\/HYPERTENSIONAHA.109.140665","volume":"55","author":"K Heusser","year":"2010","unstructured":"Heusser, K. et al. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 55, 619\u2013626 (2010).","journal-title":"Hypertension"},{"key":"BFnm4173_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1212\/WNL.0b013e3182088108","volume":"76","author":"NK Patel","year":"2011","unstructured":"Patel, N.K. et al. Deep brain stimulation relieves refractory hypertension. Neurology 76, 405\u2013407 (2011).","journal-title":"Neurology"},{"key":"BFnm4173_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/HYPERTENSIONAHA.114.02925","volume":"64","author":"AE Burchell","year":"2014","unstructured":"Burchell, A.E., Lobo, M.D., Sulke, N., Sobotka, P.A. & Paton, J.F. Arteriovenous anastomosis: is this the way to control hypertension? Hypertension 64, 6\u201312 (2014).","journal-title":"Hypertension"},{"key":"BFnm4173_CR12","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/S0140-6736(14)62053-5","volume":"385","author":"MD Lobo","year":"2015","unstructured":"Lobo, M.D. et al. Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial. Lancet 385, 1634\u20131641 (2015).","journal-title":"Lancet"},{"key":"BFnm4173_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1161\/01.CIR.97.10.943","volume":"97","author":"K Narkiewicz","year":"1998","unstructured":"Narkiewicz, K. et al. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 97, 943\u2013945 (1998).","journal-title":"Circulation"},{"key":"BFnm4173_CR14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1161\/CIRCRESAHA.109.206946","volume":"106","author":"ZY Tan","year":"2010","unstructured":"Tan, Z.Y. et al. Chemoreceptor hypersensitivity, sympathetic excitation, and overexpression of ASIC and TASK channels before the onset of hypertension in SHR. Circ. Res. 106, 536\u2013545 (2010).","journal-title":"Circ. Res."},{"key":"BFnm4173_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0306-9877(81)90109-2","volume":"7","author":"J Przybylski","year":"1981","unstructured":"Przybylski, J. Do arterial chemoreceptors play a role in the pathogenesis of hypertension? Med. Hypotheses 7, 127\u2013131 (1981).","journal-title":"Med. Hypotheses"},{"key":"BFnm4173_CR16","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1161\/01.HYP.11.6.608","volume":"11","author":"VK Somers","year":"1988","unstructured":"Somers, V.K., Mark, A.L. & Abboud, F.M. Potentiation of sympathetic nerve responses to hypoxia in borderline hypertensive subjects. Hypertension 11, 608\u2013612 (1988).","journal-title":"Hypertension"},{"key":"BFnm4173_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/cvr\/16.3.163","volume":"16","author":"A Trzebski","year":"1982","unstructured":"Trzebski, A., Tafil, M., Zoltowski, M. & Przybylski, J. Increased sensitivity of the arterial chemoreceptor drive in young men with mild hypertension. Cardiovasc. Res. 16, 163\u2013172 (1982).","journal-title":"Cardiovasc. Res."},{"key":"BFnm4173_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/hr.2011.209","volume":"35","author":"M Si\u0144ski","year":"2012","unstructured":"Si\u0144ski, M. et al. Tonic activity of carotid body chemoreceptors contributes to the increased sympathetic drive in essential hypertension. Hypertens. Res. 35, 487\u2013491 (2012).","journal-title":"Hypertens. Res."},{"key":"BFnm4173_CR19","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1113\/jphysiol.2012.237800","volume":"590","author":"AP Abdala","year":"2012","unstructured":"Abdala, A.P. et al. Hypertension is critically dependent on the carotid body input in the spontaneously hypertensive rat. J. Physiol. (Lond.) 590, 4269\u20134277 (2012).","journal-title":"J. Physiol. (Lond.)"},{"key":"BFnm4173_CR20","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/ncomms3395","volume":"4","author":"FD McBryde","year":"2013","unstructured":"McBryde, F.D. et al. The carotid body as a putative therapeutic target for the treatment of neurogenic hypertension. Nat. Commun. 4, 2395 (2013).","journal-title":"Nat. Commun."},{"key":"BFnm4173_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1161\/HYPERTENSIONAHA.111.00064","volume":"61","author":"JF Paton","year":"2013","unstructured":"Paton, J.F. et al. The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases. Hypertension 61, 5\u201313 (2013).","journal-title":"Hypertension"},{"key":"BFnm4173_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1378\/chest.40.6.595","volume":"40","author":"K Nakayama","year":"1961","unstructured":"Nakayama, K. Surgical removal of the carotid body for bronchial asthma. Dis. Chest 40, 595\u2013604 (1961).","journal-title":"Dis. Chest"},{"key":"BFnm4173_CR23","doi-asserted-by":"publisher","first-page":"ra37","DOI":"10.1126\/scisignal.2005846","volume":"8","author":"G Yuan","year":"2015","unstructured":"Yuan, G. et al. Protein kinase G-regulated production of H2S governs oxygen sensing. Sci. Signal. 8, ra37 (2015).","journal-title":"Sci. Signal."},{"key":"BFnm4173_CR24","first-page":"49","volume":"29","author":"NR Prabhakar","year":"2014","unstructured":"Prabhakar, N.R. & Peers, C. Gasotransmitter regulation of ion channels: a key step in O2 sensing by the carotid body. Physiology (Bethesda) 29, 49\u201357 (2014).","journal-title":"Physiology (Bethesda)"},{"key":"BFnm4173_CR25","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00424-015-1689-1","volume":"467","author":"KJ Buckler","year":"2015","unstructured":"Buckler, K.J. TASK channels in arterial chemoreceptors and their role in oxygen and acid sensing. Pflugers Arch. 467, 1013\u20131025 (2015).","journal-title":"Pflugers Arch."},{"key":"BFnm4173_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-94-007-4584-1_11","volume":"758","author":"AM Evans","year":"2012","unstructured":"Evans, A.M., Peers, C., Wyatt, C.N., Kumar, P. & Hardie, D.G. Ion channel regulation by the LKB1-AMPK signalling pathway: the key to carotid body activation by hypoxia and metabolic homeostasis at the whole body level. Adv. Exp. Med. Biol. 758, 81\u201390 (2012).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnm4173_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1113\/expphysiol.2014.079517","volume":"100","author":"HD Schultz","year":"2015","unstructured":"Schultz, H.D., Marcus, N.J. & Del Rio, R. Mechanisms of carotid body chemoreflex dysfunction during heart failure. Exp. Physiol. 100, 124\u2013129 (2015).","journal-title":"Exp. Physiol."},{"key":"BFnm4173_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.autneu.2015.04.005","volume":"191","author":"AP Ford","year":"2015","unstructured":"Ford, A.P. et al. P2X3 receptors and sensitization of autonomic reflexes. Auton. Neurosci. 191, 16\u201324 (2015).","journal-title":"Auton. Neurosci."},{"key":"BFnm4173_CR29","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/S0140-6736(14)61255-1","volume":"385","author":"R Abdulqawi","year":"2015","unstructured":"Abdulqawi, R. et al. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. Lancet 385, 1198\u20131205 (2015).","journal-title":"Lancet"},{"key":"BFnm4173_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1469-7793.2000.t01-1-00143.x","volume":"525","author":"M Zhang","year":"2000","unstructured":"Zhang, M., Zhong, H., Vollmer, C. & Nurse, C.A. Co-release of ATP and ACh mediates hypoxic signalling at rat carotid body chemoreceptors. J. Physiol. (Lond.) 525, 143\u2013158 (2000).","journal-title":"J. Physiol. (Lond.)"},{"key":"BFnm4173_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0006-8993(03)03366-3","volume":"988","author":"R Varas","year":"2003","unstructured":"Varas, R., Alcayaga, J. & Iturriaga, R. ACh and ATP mediate excitatory transmission in cat carotid identified chemoreceptor units in vitro. Brain Res. 988, 154\u2013163 (2003).","journal-title":"Brain Res."},{"key":"BFnm4173_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.resp.2007.01.002","volume":"157","author":"P Zapata","year":"2007","unstructured":"Zapata, P. Is ATP a suitable co-transmitter in carotid body arterial chemoreceptors? Respir. Physiol. Neurobiol. 157, 106\u2013115 (2007).","journal-title":"Respir. Physiol. Neurobiol."},{"key":"BFnm4173_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/978-3-540-79090-7_10","volume":"194","author":"G Burnstock","year":"2009","unstructured":"Burnstock, G. Purines and sensory nerves. Handb. Exp. Pharmacol. 194, 333\u2013392 (2009).","journal-title":"Handb. Exp. Pharmacol."},{"key":"BFnm4173_CR34","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.resp.2013.07.023","volume":"189","author":"G Icekson","year":"2013","unstructured":"Icekson, G., Dominguez, C.V., Dedios, V.P., Arroyo, J. & Alcayaga, J. Petrosal ganglion responses to acetylcholine and ATP are enhanced by chronic normobaric hypoxia in the rabbit. Respir. Physiol. Neurobiol. 189, 624\u2013631 (2013).","journal-title":"Respir. Physiol. Neurobiol."},{"key":"BFnm4173_CR35","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1113\/expphysiol.2014.078873","volume":"99","author":"J K\u00e5hlin","year":"2014","unstructured":"K\u00e5hlin, J. et al. The human carotid body releases acetylcholine, ATP and cytokines during hypoxia. Exp. Physiol. 99, 1089\u20131098 (2014).","journal-title":"Exp. Physiol."},{"key":"BFnm4173_CR36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1113\/jphysiol.2001.012836","volume":"537","author":"M Prasad","year":"2001","unstructured":"Prasad, M. et al. Expression of P2X2 and P2X3 receptor subunits in rat carotid body afferent neurones: role in chemosensory signalling. J. Physiol. (Lond.) 537, 667\u2013677 (2001).","journal-title":"J. Physiol. (Lond.)"},{"key":"BFnm4173_CR37","doi-asserted-by":"publisher","first-page":"11315","DOI":"10.1523\/JNEUROSCI.23-36-11315.2003","volume":"23","author":"W Rong","year":"2003","unstructured":"Rong, W. et al. Pivotal role of nucleotide P2X2 receptor subunit of the ATP-gated ion channel mediating ventilatory responses to hypoxia. J. Neurosci. 23, 11315\u201311321 (2003).","journal-title":"J. Neurosci."},{"key":"BFnm4173_CR38","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1172\/JCI108983","volume":"61","author":"MJ Welsh","year":"1978","unstructured":"Welsh, M.J., Heistad, D.D. & Abboud, F.M. Depression of ventilation by dopamine in man. Evidence for an effect on the chemoreceptor reflex. J. Clin. Invest. 61, 708\u2013713 (1978).","journal-title":"J. Clin. Invest."},{"key":"BFnm4173_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0304-3940(81)90354-2","volume":"24","author":"H Cardenas","year":"1981","unstructured":"Cardenas, H. & Zapata, P. Dopamine-induced ventilatory depression in the rat, mediated by carotid nerve afferents. Neurosci. Lett. 24, 29\u201333 (1981).","journal-title":"Neurosci. Lett."},{"key":"BFnm4173_CR40","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/j.1476-5381.2010.00796.x","volume":"160","author":"JR Gever","year":"2010","unstructured":"Gever, J.R. et al. AF-353, a novel, potent and orally bioavailable P2X3\/P2X2\/3 receptor antagonist. Br. J. Pharmacol. 160, 1387\u20131398 (2010).","journal-title":"Br. J. Pharmacol."},{"key":"BFnm4173_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4615-2966-8_1","volume":"337","author":"JA Clarke","year":"1993","unstructured":"Clarke, J.A., Daly, M.D. & Ead, H.W. Vascular analysis of the carotid body in the spontaneously hypertensive rat. Adv. Exp. Med. Biol. 337, 3\u20138 (1993).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnm4173_CR42","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1113\/jphysiol.2013.269829","volume":"592","author":"CA Nurse","year":"2014","unstructured":"Nurse, C.A. Synaptic and paracrine mechanisms at carotid body arterial chemoreceptors. J. Physiol. (Lond.) 592, 3419\u20133426 (2014).","journal-title":"J. Physiol. (Lond.)"},{"key":"BFnm4173_CR43","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1002\/jnr.22107","volume":"87","author":"J Fan","year":"2009","unstructured":"Fan, J. et al. Interleukin-6 increases intracellular Ca2+ concentration and induces catecholamine secretion in rat carotid body glomus cells. J. Neurosci. Res. 87, 2757\u20132762 (2009).","journal-title":"J. Neurosci. Res."},{"key":"BFnm4173_CR44","first-page":"267","volume":"7","author":"AP Ford","year":"2013","unstructured":"Ford, A.P. & Undem, B.J. The therapeutic promise of ATP antagonism at P2X3 receptors in respiratory and urological disorders. Front. Cell. Neurosci. 7, 267 (2013).","journal-title":"Front. Cell. Neurosci."},{"key":"BFnm4173_CR45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1113\/jphysiol.2013.262634","volume":"592","author":"DM Daly","year":"2014","unstructured":"Daly, D.M. et al. Age-related changes in afferent pathways and urothelial function in the male mouse bladder. J. Physiol. (Lond.) 592, 537\u2013549 (2014).","journal-title":"J. Physiol. (Lond.)"},{"key":"BFnm4173_CR46","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/978-3-642-16499-6_22","volume":"202","author":"AP Ford","year":"2011","unstructured":"Ford, A.P. & Cockayne, D.A. ATP and P2X purinoceptors in urinary tract disorders. Handb. Exp. Pharmacol. 202, 485\u2013526 (2011).","journal-title":"Handb. Exp. Pharmacol."},{"key":"BFnm4173_CR47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.autneu.2015.04.006","volume":"191","author":"D Adriaensen","year":"2015","unstructured":"Adriaensen, D., Brouns, I. & Timmermans, J.P. Sensory input to the central nervous system from the lungs and airways: A prominent role for purinergic signalling via P2X2\/3 receptors. Auton. Neurosci. 191, 39\u201347 (2015).","journal-title":"Auton. Neurosci."},{"key":"BFnm4173_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11302-013-9397-9","volume":"10","author":"G Burnstock","year":"2014","unstructured":"Burnstock, G. Purinergic signalling in the gastrointestinal tract and related organs in health and disease. Purinergic Signal. 10, 3\u201350 (2014).","journal-title":"Purinergic Signal."},{"key":"BFnm4173_CR49","doi-asserted-by":"publisher","first-page":"e0123810","DOI":"10.1371\/journal.pone.0123810","volume":"10","author":"A Deiteren","year":"2015","unstructured":"Deiteren, A. et al. P2X3 receptors mediate visceral hypersensitivity during acute chemically-induced colitis and in the post-inflammatory phase via different mechanisms of sensitization. PLoS One 10, e0123810 (2015).","journal-title":"PLoS One"},{"key":"BFnm4173_CR50","first-page":"1","volume":"1","author":"J Li","year":"2014","unstructured":"Li, J., Xing, J. & Lu, J. Nerve growth factor, muscle afferent receptors and autonomic responsiveness with femoral artery occlusion. J. Mod. Physiol. Res 1, 1\u201318 (2014).","journal-title":"J. Mod. Physiol. Res"},{"key":"BFnm4173_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejphar.2012.05.008","volume":"688","author":"RR Hansen","year":"2012","unstructured":"Hansen, R.R. et al. Chronic administration of the selective P2X3, P2X2\/3 receptor antagonist, A-317491, transiently attenuates cancer-induced bone pain in mice. Eur. J. Pharmacol. 688, 27\u201334 (2012).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnm4173_CR52","first-page":"1043","volume":"296","author":"M Liu","year":"2001","unstructured":"Liu, M. et al. Coexpression of P2X(3) and P2X(2) receptor subunits in varying amounts generates heterogeneous populations of P2X receptors that evoke a spectrum of agonist responses comparable to that seen in sensory neurons. J. Pharmacol. Exp. Ther. 296, 1043\u20131050 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnm4173_CR53","doi-asserted-by":"publisher","first-page":"33949","DOI":"10.1074\/jbc.M705840200","volume":"282","author":"Z Gerevich","year":"2007","unstructured":"Gerevich, Z. et al. Dual effect of acid pH on purinergic P2X3 receptors depends on the histidine 206 residue. J. Biol. Chem. 282, 33949\u201333957 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnm4173_CR54","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.tins.2009.07.007","volume":"32","author":"DB Reichling","year":"2009","unstructured":"Reichling, D.B. & Levine, J.D. Critical role of nociceptor plasticity in chronic pain. Trends Neurosci. 32, 611\u2013618 (2009).","journal-title":"Trends Neurosci."},{"key":"BFnm4173_CR55","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroscience.2014.11.020","volume":"285","author":"JG Schiavuzzo","year":"2015","unstructured":"Schiavuzzo, J.G. et al. Muscle hyperalgesia induced by peripheral P2X3 receptors is modulated by inflammatory mediators. Neuroscience 285, 24\u201333 (2015).","journal-title":"Neuroscience"},{"key":"BFnm4173_CR56","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1113\/jphysiol.2008.154187","volume":"586","author":"DB Zoccal","year":"2008","unstructured":"Zoccal, D.B. et al. Increased sympathetic outflow in juvenile rats submitted to chronic intermittent hypoxia correlates with enhanced expiratory activity. J. Physiol. (Lond.) 586, 3253\u20133265 (2008).","journal-title":"J. Physiol. (Lond.)"},{"key":"BFnm4173_CR57","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1161\/HYPERTENSIONAHA.113.02283","volume":"63","author":"DJ Moraes","year":"2014","unstructured":"Moraes, D.J., Machado, B.H. & Paton, J.F. Specific respiratory neuron types have increased excitability that drive presympathetic neurones in neurogenic hypertension. Hypertension 63, 1309\u20131318 (2014).","journal-title":"Hypertension"},{"key":"BFnm4173_CR58","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1172\/JCI115221","volume":"87","author":"VK Somers","year":"1991","unstructured":"Somers, V.K., Mark, A.L. & Abboud, F.M. Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans. J. Clin. Invest. 87, 1953\u20131957 (1991).","journal-title":"J. Clin. Invest."},{"key":"BFnm4173_CR59","first-page":"110","volume":"48","author":"JH Comroe Jr.","year":"1952","unstructured":"Comroe, J.H. Jr. The functions of the lung. Harvey Lect. 48, 110\u2013143 (1952-1953).","journal-title":"Harvey Lect."},{"key":"BFnm4173_CR60","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0165-0270(95)00147-6","volume":"65","author":"JFR Paton","year":"1996","unstructured":"Paton, J.F.R. A working heart-brainstem preparation of the mouse. J. Neurosci. Methods 65, 63\u201368 (1996).","journal-title":"J. Neurosci. Methods"},{"key":"BFnm4173_CR61","doi-asserted-by":"publisher","first-page":"19223","DOI":"10.1523\/JNEUROSCI.3041-13.2013","volume":"33","author":"DJ Moraes","year":"2013","unstructured":"Moraes, D.J. et al. Electrophysiological properties of rostral ventrolateral medulla presympathetic neurons modulated by the respiratory network in rats. J. Neurosci. 33, 19223\u201319237 (2013).","journal-title":"J. Neurosci."},{"key":"BFnm4173_CR62","unstructured":"Waynforth, H.B. & Flecknell, P. Experimental and surgical techniques in the rat. 2nd edn.382 (Academic Press, London, 1992)."},{"key":"BFnm4173_CR63","doi-asserted-by":"publisher","first-page":"6219","DOI":"10.1113\/jphysiol.2011.218099","volume":"589","author":"MK Stickland","year":"2011","unstructured":"Stickland, M.K. et al. Carotid chemoreceptor modulation of blood flow during exercise in healthy humans. J. Physiol. (Lond.) 589, 6219\u20136230 (2011).","journal-title":"J. Physiol. (Lond.)"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.4173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.4173","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.4173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:58:50Z","timestamp":1684436330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.4173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,5]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["BFnm4173"],"URL":"https:\/\/doi.org\/10.1038\/nm.4173","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726713713.793524043","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.726713713.793522943","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.726713713.793561223","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,5]]},"assertion":[{"value":"2 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.P.F. is Chief Scientific Officer for Afferent Pharmaceuticals. The other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}